SCHEMBL1886385

SCHEMBL1886385

CC(C#N)c1cccc(N)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.42
CASP1 P29466 1/20 0.42
RECQL P46063 1/20 0.42
CPN1 P15169 1/20 0.39
CPB2 Q96IY4 1/20 0.39
TSHR P16473 1/20 0.38
ALDH1A1 P00352 4/20 0.36
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA9 Q16790 2/20 0.35
CA12 O43570 1/20 0.35
CA7 P43166 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CA14 Q9ULX7 1/20 0.35
MAPKAPK2 P49137 1/20 0.35
ADRB1 P08588 1/20 0.35
MIF P14174 1/20 0.35
HTR2A P28223 1/20 0.35
ADRA1A P35348 1/20 0.35
HTR2B P41595 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chlorobenzene SCHEMBL28794910 0.88 ALDH1A1 (0.44) CYP3A4CPN1CPB2TSHRALDH1A1
SCHEMBL5982792 0.80 CYP3A4 (0.42) CYP3A4CASP1RECQLCPN1CPB2
SCHEMBL689304 0.79 HDAC4 (0.42) CYP3A4TSHRALDH1A1CA1CA2
SCHEMBL6557765 0.78 ALDH1A1 (0.47) TSHRALDH1A1MAPKAPK2TRPA1ESR1
SCHEMBL104340 0.76 CYP3A4 (0.52) CYP3A4CASP1RECQLCPN1CPB2
SCHEMBL30349751 0.76 CYP3A4 (0.52) CYP3A4CASP1RECQLCPN1CPB2
SCHEMBL272384 0.76 CYP3A4 (0.52) CYP3A4CASP1RECQLCPN1CPB2
SCHEMBL957610 0.76 IDO1 (0.41) CYP3A4ALDH1A1MAOACYP2D6SLC6A2
SCHEMBL7554338 0.76 ESR1 (0.58) CYP3A4TSHRALDH1A1CA2CA9
SCHEMBL1888368 0.76 CTSB (0.35) CYP3A4TSHRALDH1A1CYP2D6SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4499026-A Nucleophilic substitution process ETHYL CORPORATION (US) 1985-02-12 US claimed
JP-60036466-A None JP disclosed
CN-101184726-B 2-arylpropionic acid derivatives and pharmaceutical compositions containing them DOMPE PHA R MA SPA RES & MFG 2012-05-30 CN disclosed
US-8080552-B2 Pyrimidyl derivatives as protein kinase inhibitors HOFFMANN-LA ROCHE INC. (US) 2011-12-20 US disclosed
CN-101541766-B Pyrimidyl derivatives as protein kinase inhibitors HOFFMANN LA ROCHE 2011-07-27 CN disclosed
US-7939521-B2 2-arylpropionic acid derivatives and pharmaceutical compositions containing them DompePHA.R.MA S.p.A. (IT) 2011-05-10 US disclosed
EP-2102173-B1 PYRIMIDYL DERIVATIVES AS PROTEIN KINASE INHIBITORS HOFFMANN LA ROCHE (CH) 2010-10-20 EP disclosed
US-20100041684-A1 PYRIMIDYL DERIVATIVES AS PROTEIN KINASE INHIBITORS HOFFMANN-LA ROCHE, INC. 2010-02-18 US disclosed
EP-2102173-A1 PYRIMIDYL DERIVATIVES AS PROTEIN KINASE INHIBITORS F. Hoffmann-Roche AG (CH) 2009-09-23 EP disclosed
CN-101541766-A Pyrimidyl derivatives as protein kinase inhibitors HOFFMANN LA ROCHE (CH) 2009-09-23 CN disclosed
WO-2008077548-A1 PYRIMIDYL DERIVATIVES AS PROTEIN KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2008-07-03 WO disclosed
CN-101184726-A 2-arylpropionic acid derivatives and pharmaceutical compositions containing them DOMPE PHA R MA SPA RES & MFG (IT) 2008-05-21 CN disclosed
EP-1856031-A1 2-ARYLPROPIONIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DOMPE' pha.r.ma s.p.a. (IT) 2007-11-21 EP disclosed
WO-2006063999-A1 2-ARYLPROPIONIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DOMPE' PHA.R.MA.S.P.A. (IT) 2006-06-22 WO disclosed
US-4502996-A Nucleophilic substitution process ETHYL CORPORATION (US) 1985-03-05 US disclosed
JP-S6036466-A PYRIMIDYLAMINO-SUBSTITUTED PHENYLACETIC ACID DERIVATIVE HOKURIKU SEIYAKU CO LTD 1985-02-25 JP disclosed
US-4499026-A Nucleophilic substitution process ETHYL CORPORATION (US) 1985-02-12 US disclosed
US-4323388-A Cyanoalkyl-phenylureas having selective herbicidal activity CIBA-GEIGY CORPORATION (US) 1982-04-06 US disclosed
US-4243606-A AZO DYE COUPLER INTERMEDIATES PRODUITS CHIMIQUES UGINE KUHLMANN (FR) 1981-01-06 US disclosed
US-4218369-A FOR DYEING POLYACRYLONITRILE PRODUITS CHIMIQUES UGINE KUHLMANN (FR) 1980-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041684-A1 PYRIMIDYL DERIVATIVES AS PROTEIN KINASE INHIBITORS MAP3K5, MAP3K1, MAP4K2 CYP3A4 1796/4885CASP1 3002/4885RECQL 1063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.